The new MR 7700 imaging system features an enhanced gradient system for superior performance and precision, and integrates artificial intelligence (AI) for improved diagnostic outcomes

philips-mr-7700-product-image-3.download

Philips MR 7700 Product Shot. (Credit: Koninklijke Philips N.V.)

Health technology firm Royal Philips has obtained the US Food and Drug Administration (FDA) 510(k) approval for its new MR 7700 3.0T MR system.

The MR 7700 3.0T represents the latest advancement in the company’s MR technology, designed to offer superior performance and precision for research and clinical diagnostics.

It features XP gradients for enhanced accuracy and artificial intelligence (AI) technology for improved workflow, to facilitate better patient care and reduce costs.

Philips said that its latest MR product will expand the scanning capabilities with a fully integrated multi-nuclei imaging and spectroscopy solution.

It helps explore new clinical pathways, while not compromising on clinical imaging workflow or wide-bore patient comfort, and enhances both staff and patient experience.

Philips magnetic resonance and diagnostic X-ray general manager Arjen Radder said: “Enhanced with ultra-high gradients and artificial intelligence, Philips MR 7700 is built to deliver on the high-quality clinical performance expectations of today, and to facilitate the most demanding and promising research programs that will help drive the future of MR imaging, without sacrificing workflow efficiency or wide-bore patient comfort.

“Combined with its AI-driven smart connected imaging capabilities, optimized workflows and integrated clinical solutions help meet the quadruple aim of healthcare by improving MR department productivity, enhancing the patient and staff experience, helping to deliver high-quality diagnostic outcomes.”

The new MR 7700 comes with multi-nuclei integration capabilities, allowing radiologists to image six different clinically relevant nuclei across all anatomies, and adds crucial metabolic information to MR exams.

It comes with an intuitive user-friendly interface that enables all imaging protocols to be easily accessible and contributes to effective radiology workflows and first-time-right scans.

The XP gradient coils used in the device are said to achieve up to 35% higher signal-to-noise ratios and reduce scan times by up to 35%.

It enables radiologists to achieve 20% more fMRI volumes and 50% more diffusion tensor imaging (DTI) directions and offers high-resolution images to identify and characterise lesions.

MR 7700 comes with an automated SmartWorkflow technology, and in-built MR protocols to combine proton imaging with imaging based on sodium, phosphorus, carbon, fluorine, and xenon.

Furthermore, MR 7700 enables AI-driven touchless patient sensing and motion detection, to address the increasing patient volumes in the radiology departments.

The AI-driven smart connected imaging, optimised workflows and integrated clinical solutions will help improve the effectiveness of MR procedures, and enhance patient and staff experience, said Philips.